Based on the barriers to integration of immunotherapies identified by the sites participating in the quality improvement project, the following webinars were developed to address specific challenges, providing training and tools to support all members of the multidisciplinary team involved in the care of patients treated with immunotherapy for cancer.
Ali McBride, PharmD, MS, BCOP, and Igor Puzanov, MD, MSCI, FACP
Review the latest IO approvals and new indications and hear about IO combination therapies, combination considerations, and how to approach IO doublet therapy for your patient.
View Webinar
Ali McBride, PharmD, MS, BCOP, and Joanne Riemer, RN, BSN
With expanding approvals and indications for immuno-oncology, the understanding of irAEs continues to evolve. Early recognition and management of irAEs is critical as these side can quickly become serious. This presentation covers effective practices to recognize, grade, evaluate, treat, and follow-up on irAEs. The faculty discuss three irAE case studies and resources on managing immune-related toxicities.
View Webinar
Matthew Zibelman, MD, and Joanne Riemer, RN, BSN
As experience with new immunotherapies and combination therapies increases, understanding of less commonly occurring irAEs continues to expand. Learn how two academic medical centers are developing institution-level strategies to optimize the management of rare irAEs in patients receiving immunotherapies.
View Webinar
Igor Puzanov, MD, MSCI, FACP, and Matthew Zibelman, MD
Hear an interactive dialogue between these experts on considerations for patient selection when individuals have existing comorbidities, monitoring and managing irAEs, consistent grading of AEs, care coordination with providers outside the oncology team, and patient education on how to recognize early signs and symptoms of adverse reactions.
View Webinar
Supported by a grant from Genentech
